Trading Signals: CGEN Stock Price Prediction and Forecast (Wed. Jun. 11, 2003 - Fri. May. 13, 2022)(Compugen Ltd.)
| CGEN latest price $6.9700 (-3.99%) ($6.8000 - $7.2600) on Wed. Apr. 1, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 6.57% (three month average) | RSI | 41 | Latest Price | $6.9700(-3.99%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CGEN declines -1.4% a day on average for past five trading days. | Weekly Trend | CGEN declines -2.3% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support CGEN advance at 0% a week (0% probability) ARKG(68%) XBI(66%) ARKK(64%) IBB(61%) IPO(56%) | Factors Impacting CGEN price | CGEN will decline at least -3.285% in a week (0% probabilities). VXX(-35%) VIXM(-30%) UUP(-18%) IGOV(-5%) TBT(-2%) | | | | | Relative Volatility | | | | Market Trend Strength | -3.285% (StdDev 6.57%) | Hourly BBV | 0 () | Intraday Trend | 0.4% | | | |
|
Resistance Level | $7.99 | 5 Day Moving Average | $7.23(-3.6%) | 10 Day Moving Average | $7.07(-1.41%) | 20 Day Moving Average | $7.99(-12.77%) | To recent high | -41.1% | To recent low | 20.4% | Market Cap | $576m | | | | Compugen Ltd. engages in the research, development, and commercialization of therapeutic and diagnostic biomarker product candidates including proteins and monoclonal antibodies. It focuses its research and development on immuno-oncology and autoimmune diseases. The company was founded by Eli Mintz, Simchon Faigler, and Amir Natan on February 10, 1993 and is headquartered in Holon, Israel. |